Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD

1.110

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

1.140

+0.030 (2.70%)

Pre-market: Jul 22, 2024, 7:18 AM EDT

Bone Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2007
Selling, General & Admin	2.62	2.52	2.09	1.02	0.48	1.35	Upgrade
Research & Development	4.56	6.91	1.58	0.08	0.34	1.1	Upgrade
Operating Expenses	7.18	9.43	3.67	1.1	0.83	2.45	Upgrade
Operating Income	-7.18	-9.43	-3.67	-1.1	-0.83	-2.45	Upgrade
Interest Expense / Income	0	0	0	0.81	1	0.98	Upgrade
Other Expense / Income	-1.08	-0.48	-2.18	-0.3	-	-	Upgrade
Pretax Income	-6.1	-8.95	-1.48	-1.61	-1.82	-3.42	Upgrade
Income Tax	0	0	0	0	0	0	Upgrade
Net Income	-6.1	-8.95	-1.48	-1.61	-1.82	-3.42	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	0	Upgrade
Shares Change	883.36%	452.14%	151.84%	56.01%	-0.17%	45.07%	Upgrade
EPS (Basic)	-16.34	-34.01	-31.15	-84.00	-151.20	-282.00	Upgrade
EPS (Diluted)	-16.34	-34.01	-31.15	-84.00	-151.20	-282.00	Upgrade
Free Cash Flow	-9.51	-9.56	-3.57	-1.23	-0.43	-3.25	Upgrade
Free Cash Flow Per Share	-14.39	-36.31	-74.84	-64.92	-35.20	-267.57	Upgrade
EBITDA	-6.1	-8.95	-1.48	-0.81	-0.83	-2.45	Upgrade
Depreciation & Amortization	0	0	0	0	0	0	Upgrade
EBIT	-6.1	-8.95	-1.48	-0.81	-0.83	-2.45	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).